Precision BioSciences Inc buy BMO Capital Markets
Start price
10.01.25
/
50%
€0.35
Target price
10.01.26
€33.15
Performance (%)
-
End price
11.01.26
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Precision BioSciences Inc | - | - | - |
| iShares Core DAX® | 3.023% | 2.202% | 14.664% |
| iShares Nasdaq 100 | 3.561% | 1.325% | 31.410% |
| iShares Nikkei 225® | 6.618% | 5.707% | 49.420% |
| iShares S&P 500 | 2.635% | 1.008% | 25.116% |
Comments by BMO_Capital_Markets for this prediction
In the thread Precision BioSciences Inc diskutieren
Precision BioSciences, Inc. (NASDAQ: DTIL) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating. They now have a $34.00 price target on the stock.
Ratings data for DTIL provided by MarketBeat
In the thread Trading Precision BioSciences Inc
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten